To prospectively compare two commonly used methods for percutaneous dilational tracheostomy (PDT) in critically ill patients.
Prospective, randomized, clinical trial.
Trauma and general intensive care units of a university tertiary teaching hospital, which is also a level 1 trauma center.
One hundred critically ill patients with an indication for PDT.
PDT with the Ciaglia technique using the Ciaglia PDT introducer set and the Griggs technique using a Griggs PDT kit and guidewire dilating forceps.
Surgical time, difficulties, and surgical and anesthesia complications were measured at 0–2 hrs, 24 hrs, and 7 days postprocedure. Groups were well matched, and there were no differences between the two methods in surgical time or in anesthesia complications. Major bleeding complications were 4.4 times more frequent with the Griggs PDT kit. With the Ciaglia PDT kit, both intraoperative and at 2 and 24 hrs, surgical complications were less common (p = .023) and the procedure was more often completed without expert assistance (p = .013). Tracheostomy bleeding was not associated with either anticoagulant therapy or an abnormal clotting profile. Multivariate analysis identified the predictors of PDT complications as the Griggs PDT kit (p = .027) and the Acute Physiology and Chronic Health Evaluation (APACHE) II score (p = .041). The significant predictors of time required to complete PDT were the APACHE II score (p = .041), a less experienced operator (p = .0001), and a female patient (p = .013).
Patients experiencing PDT with the Ciaglia PDT kit had a lower surgical complication rate (2% vs. 25%), less operative and postoperative bleeding, and less overall technical difficulties than did patients undergoing PDT with the Griggs PDT kit. Ciaglia PDT is, therefore, the preferred technique for percutaneous tracheostomy in critically ill patients.
From the Departments of Intensive Care and Hyperbaric Medicine (Drs. Nates, Cooper, Scheinkestel, and Tuxen) and Anesthesia (Dr. Myles), The Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia.
Address requests for reprints to: Joseph L. Nates, MD, Departments of Neurosurgery and Anesthesia-Critical Care Medicine, The University of Texas-Houston, Health Science Center Medical School, 6410 Fannin, HPB 1020, Houston, TX 77030. E-mail: email@example.com
This study was completed without any involvement from Cook Critical Care or Portex. We did not have any involvement of any type with either company.